Dalrada-Corporation-logo-400.png
Dalrada Financial Corporation Healthcare Subsidiary, Genefic, Inc., Acquires IV Services Infusion Pharmacy
21 mai 2024 08h45 HE | Dalrada Financial Corp.
Company enters $42 billion marketplace with acquisition of established and successful infusion pharmacy.
Dalrada-Corporation-logo-400.png
Dalrada Financial Corporation Files Form 10-Q, Announces Third Quarter Revenue of $10.3 Million
16 mai 2024 08h45 HE | Dalrada Financial Corp.
Company’s pharmaceutical subsidiary continues to drive impressive growth accounting for nearly 80% of Q3 2024 revenue
Dalrada-Corporation-logo-400.png
Dalrada Financial Corporation’s Wholly-Owned Subsidiary, Genefic, Inc. Announces New Telemedicine Services, Enters Booming Weight Loss Drug Market
23 avr. 2024 08h00 HE | Dalrada Financial Corp.
OTCQB: DFCO subsidiary announces entry into the global weight loss drug market currently worth approximately $6 billion